Clinical Trials Browser

Terminated × Everolimus × Dermatologic × Clear all

NCT01637090 2017-01-12

CTCL

Phase 2 Terminated

3 enrolled 6 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00402662 2013-12-18

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

Phase 2 Terminated

Melanoma